VIL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, neither acrylamide nor CML increased intestinal permeability evaluated by FITC-Dextran efflux, although we observed a lower expression of TJP1 and VIL1 mRNA after CML stimulation compared to acrylamide exposure, but not compared to the non-stimulated cells.